Editas Medicine wins CRISPR patent ruling from USPTO
Go back to Editas Medicine wins CRISPR patent ruling from USPTO| (NASDAQ: EDIT) | Delayed: 2.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.60 | 52 Week High | $43.99 | |||
| Open | $2.60 | 52 Week Low | $12.43 | |||
| Day High | $2.60 | P/E | N/A | |||
| Day Low | $2.60 | EPS | $0.00 | |||
| Volume | 83 | |||||
